A study to evaluate the impact of a program to facilitate transfer of medical management of Indian adolescents with diabetes to adult care providers.
Not Applicable
- Conditions
- Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2020/10/028379
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Established T1DM with duration of = 1 year, Age between 16.5 and 19.5 years at the time of recruitment,Resident of Delhi NCR, At least one visit during the previous year with the paediatric care provider at the participating centre, Ability to participate in all aspects of the clinical trial, Willing to provide written informed consent/assent.
Exclusion Criteria
Pregnant or lactating females or those who plan to become pregnant during the next 3 years,
Condition(s) which may interfere with the subject’s ability to participate in the study in the opinion of the investigator, Participation in another clinical trial within 6 months prior to enrolment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proposed primary outcome of the trial will be the difference between the intervention and control group in terms of post transition clinic attendance rate.Timepoint: 1 year after the end of intervention.
- Secondary Outcome Measures
Name Time Method The secondary outcomes include comparison of process indicators like adherence to diabetes care, self-care practices, quality of life, diabetes treatment satisfaction, diabetes distress, HbA1c values, transition readiness, transition satisfaction, proportion undergoing diabetes complication screening and biological endpoints (post transition glycemic control and incidence of hypo glycaemia and diabetes keto acidosis) between the intervention and the control group.Timepoint: 1 year after the end of intervention.